🔎 Trials Near Me

Home › Multiple Myeloma › New York › Rochester

Multiple Myeloma clinical trials in Rochester, NY

8 studies for Multiple Myeloma are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

RecruitingPhase 2
  • University of Rochester Medical Center, Rochester
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06500884

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 2
  • University of Rochester Medical Center, Rochester
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04634552

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

RecruitingPhase 3
  • University of Rochester, Rochester
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04566328

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

RecruitingPhase 3
  • University of Rochester, Rochester
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

RecruitingPhase 1
  • University of Rochester Medical Center, Rochester
Ages 18 and older · All sexes · Updated May 19, 2026 · NCT06433947

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

RecruitingPhase 2
  • Wilmot Cancer Center, Clinical Trial Office of the University of Rochester Medical Center, Rochester
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06993675

Umbilical Cord Blood Transplantation From Unrelated Donors

RecruitingObservational study
  • Wilmot Cancer Institute, Rochester
2 Months – 75 Years · All sexes · Updated Oct 10, 2025 · NCT03016806

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

RecruitingPhase 2
  • University of Rochester, Rochester
Ages 18 and older · All sexes · Updated Feb 10, 2025 · NCT05597345

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.